Protara Therapeutics, Inc.TARANASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-48.82M
↓ 42% below average
Average (9y)
$-34.38M
Historical baseline
Range
High:$-7.81M
Low:$-64.57M
CAGR
+9.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-48.82M | -12.8% |
| 2023 | $-43.27M | +33.0% |
| 2022 | $-64.57M | -42.2% |
| 2021 | $-45.40M | -34.4% |
| 2020 | $-33.78M | -332.3% |
| 2019 | $-7.81M | +62.1% |
| 2018 | $-20.61M | +30.9% |
| 2017 | $-29.82M | -5.0% |
| 2016 | $-28.40M | -33.2% |
| 2015 | $-21.32M | - |